23andMe to slash 40% of its workforce, end therapeutics program to cut costs
Read more at MarketWatch
-
23andMe cuts 40% of its workforce and discontinues therapeutics division
Health - ABC News - November 12 -
Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles
World - The Guardian - November 12 -
23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
Business - Inc. - November 12 -
23andMe to lay off 40% of its workforce as stock price plummets
Top stories - CBS News - November 12 -
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Business - CNBC - November 12 -
DNA-testing site 23andMe to lay off 40% of its workers
Top stories - BBC News - November 12 -
Musk, Ramaswamy publish plan to slash workforce
Politics - Politico - 2 days ago -
The Associated Press says buyouts and some layoffs are ahead as it seeks to cut its workforce by 8%
Entertainment - ABC News - 4 days ago
More from MarketWatch
-
Trump’s Treasury pick is Scott Bessent. He’s said it’s absurd to fear ‘Trump-flation.’
Business - MarketWatch - 6 hours ago -
Investors can look ahead to Nvidia, Treasury bonds and a bullish finish to 2024
Business - MarketWatch - 8 hours ago -
Hoping for an OpenAI or Anthropic IPO? Here’s why that’s unlikely anytime soon.
Business - MarketWatch - 9 hours ago -
Qualcomm is moving fast to boost growth and trim its dependence on Apple
Business - MarketWatch - 9 hours ago -
Nvidia continues its march to a $4 trillion stock-market valuation. Why it’s inevitable.
Business - MarketWatch - 10 hours ago